A Study of LY317615 in Patients With Brain Tumors

Clinical trial NCT00190723 · COMPLETED

Trial details

NCT number: NCT00190723
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2002-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.